Novo CEO pressed by Senate to chop costs of obesity, diabetic issues drugs CEO Lars Fruergaard Jørgensen explained to lawmakers the company would take into account new talks with insurers in regards to the record costs of Wegovy and copyright when they pledge to help keep the medicines on their https://elliotjcsjz.blogars.com/29829009/5-essential-elements-for-healthcare-news